Survivors of stroke and transient ischaemic attacks are at risk of a recurrent stroke, which is
often more severe and disabling than the index event. Optimum secondary prevention of …

Stroke is a major cause of death and disability worldwide. Without improvements in
prevention, the burden will increase during the next 20 years because of the ageing …

Background The incidence of stroke is predicted to rise because of the rapidly ageing
population. However, over the past two decades, findings of randomised trials have …

Along with the rising global burden of disability attributed to stroke, costs of stroke care are
rising, providing the impetus to direct our research focus towards effective measures of …

Background Evidence is available on the effectiveness and costs of treatments to reduce
stroke risk in long-term secondary prevention. However, there are few data on the costs and …

The global burden of stroke and dementia are increasing. If current trends continue, by 2050
we can expect about 200 million stroke survivors and 106 million people with dementia, and …

Background Patients with recent stroke or transient ischaemic attack are at high risk for a
further vascular event, possibly leading to permanent disability or death. Although evidence …

Stroke caused an estimated 5· 7 million deaths in 2005, and 87% of these deaths were in
low-income and middle-income countries. Without intervention, the number of global deaths …

Aspirin is widely used for the prevention of recurrent stroke in patients with transient
ischaemic attack (TIA) and ischaemic stroke of arterial origin, because it is effective and …

Every year, approximately 62 000 people with stroke and transient ischemic attack are
treated in Canadian hospitals. The 2014 update of the Canadian Secondary Prevention of …